Albert J. Siemens, PhD
Chairman, Novella Clinical
Chairman and Chief Executive Officer, FHI 360
Dr. Siemens has served as Chairman of Novella Clinical since 1999, also serving as CEO from 1999 to 2007. He also has executive leadership responsibility for FHI 360, a global health and social development organization, serving as CEO since 1998 and Chairman of the Board since 2006.
Dr. Siemens was Executive Vice President of ClinTrials Research from 1991 through 1997 with responsibility for international development. He was President of Clinical Research International (CRI), an FHI affiliate, from 1988 until the company was acquired by ClinTrials Research in late 1990. In 1986, as FHI’s Vice President of Research, he was instrumental in the formation of CRI, the world’s first full-service, multinational clinical research service company.
Dr. Siemens initially joined FHI in 1983 as Director of Clinical Trials to lead multinational contraceptive clinical research. His career in product development began at Pfizer, where he was responsible for clinical studies of cardiovascular, antibiotic, anti-inflammatory, and psychotropic agents in the company’s domestic and international divisions. His clinical research background is augmented by seven years of research management and teaching experience in pharmacology at the Research Institute on Alcoholism and the State University of New York at Buffalo.
Dr. Siemens holds BSc (Pharmacy) and MSc degrees from the University of Manitoba and a PhD in Pharmacology from the University of Toronto.